APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bupropion Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Bupropion Tablets Market Outlook and Growth Opportunities 2026

29 December 2025209 pages

Choose your research edition.

Industry ResearchBupropion Tablets Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Bupropion Tablets Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Bupropion Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bupropion Tablets Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Bupropion Tablets Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Bupropion Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Bupropion Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bupropion Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bupropion Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Bupropion Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Bupropion Tablets market include GSK, Yichang Humanwell Pharmaceutical, Sinotherapeutics, CSPC Ouyi Pharmaceutical, Luye Pharma, Disha Pharmaceutical, Zydus, Watson Laboratories and TWi Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Bupropion Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bupropion Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bupropion Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bupropion Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Bupropion Tablets Segment by Company

GSK

Yichang Humanwell Pharmaceutical

Sinotherapeutics

CSPC Ouyi Pharmaceutical

Luye Pharma

Disha Pharmaceutical

Zydus

Watson Laboratories

TWi Pharmaceuticals

Sun Pharma

ScieGen Pharmaceuticals

Sandoz

Lupin

Impax Laboratories

Epic Pharma

Bausch

Aurobindo Pharma

Apotex

Alembic

Accord Healthcare

Bupropion Tablets Segment by Type

Immediate-release Tablets

Extended-release Tablets

Bupropion Tablets Segment by Application

Major Depressive Disorder

Assisted Smoking Cessation

Other

Bupropion Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Bupropion Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Bupropion Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Bupropion Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Bupropion Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bupropion Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bupropion Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bupropion Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Bupropion Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bupropion Tablets industry.

Chapter 3: Detailed analysis of Bupropion Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Bupropion Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Bupropion Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Bupropion Tablets Industry Trends Table 2. Bupropion Tablets Industry Drivers Table 3. Bupropion Tablets Industry Opportunities and Challenges Table 4. Bupropion Tablets Industry Restraints Table 5. Global Bupropion Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Bupropion Tablets Revenue Share by Company (2021-2026) Table 7. Global Bupropion Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Bupropion Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Bupropion Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Bupropion Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Bupropion Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Bupropion Tablets Company, Product Type & Application Table 13. Global Bupropion Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Bupropion Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Immediate-release Tablets Table 18. Significant Companies of Extended-release Tablets Table 19. Global Bupropion Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Bupropion Tablets Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Bupropion Tablets Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Bupropion Tablets Sales Volume Share by Type (2021-2026) Table 23. Global Bupropion Tablets Sales Volume Share by Type (2027-2032) Table 24. Global Bupropion Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Bupropion Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Bupropion Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Bupropion Tablets Sales Value Share by Type (2021-2026) Table 28. Global Bupropion Tablets Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Major Depressive Disorder Table 30. Significant Companies of Assisted Smoking Cessation Table 31. Significant Companies of Other Table 32. Global Bupropion Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Bupropion Tablets Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Bupropion Tablets Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Bupropion Tablets Sales Volume Share by Application (2021-2026) Table 36. Global Bupropion Tablets Sales Volume Share by Application (2027-2032) Table 37. Global Bupropion Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Bupropion Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Bupropion Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Bupropion Tablets Sales Value Share by Application (2021-2026) Table 41. Global Bupropion Tablets Sales Value Share by Application (2027-2032) Table 42. Global Bupropion Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Bupropion Tablets Sales by Region (2021-2026) & (K Units) Table 44. Global Bupropion Tablets Sales Market Share by Region (2021-2026) Table 45. Global Bupropion Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Bupropion Tablets Sales Market Share by Region (2027-2032) Table 47. Global Bupropion Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Bupropion Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Bupropion Tablets Sales Value Share by Region (2021-2026) Table 50. Global Bupropion Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Bupropion Tablets Sales Value Share by Region (2027-2032) Table 52. Global Bupropion Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Bupropion Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Bupropion Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Bupropion Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Bupropion Tablets Sales by Country (2021-2026) & (K Units) Table 57. Global Bupropion Tablets Sales Market Share by Country (2021-2026) Table 58. Global Bupropion Tablets Sales by Country (2027-2032) & (K Units) Table 59. Global Bupropion Tablets Sales Market Share by Country (2027-2032) Table 60. Global Bupropion Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Bupropion Tablets Sales Value Market Share by Country (2021-2026) Table 62. Global Bupropion Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Bupropion Tablets Sales Value Market Share by Country (2027-2032) Table 64. GSK Company Information Table 65. GSK Business Overview Table 66. GSK Bupropion Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. GSK Bupropion Tablets Product Portfolio Table 68. GSK Recent Development Table 69. Yichang Humanwell Pharmaceutical Company Information Table 70. Yichang Humanwell Pharmaceutical Business Overview Table 71. Yichang Humanwell Pharmaceutical Bupropion Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Yichang Humanwell Pharmaceutical Bupropion Tablets Product Portfolio Table 73. Yichang Humanwell Pharmaceutical Recent Development Table 74. Sinotherapeutics Company Information Table 75. Sinotherapeutics Business Overview Table 76. Sinotherapeutics Bupropion Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Sinotherapeutics Bupropion Tablets Product Portfolio Table 78. Sinotherapeutics Recent Development Table 79. CSPC Ouyi Pharmaceutical Company Information Table 80. CSPC Ouyi Pharmaceutical Business Overview Table 81. CSPC Ouyi Pharmaceutical Bupropion Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. CSPC Ouyi Pharmaceutical Bupropion Tablets Product Portfolio Table 83. CSPC Ouyi Pharmaceutical Recent Development Table 84. Luye Pharma Company Information Table 85. Luye Pharma Business Overview Table 86. Luye Pharma Bupropion Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Luye Pharma Bupropion Tablets Product Portfolio Table 88. Luye Pharma Recent Development Table 89. Disha Pharmaceutical Company Information Table 90. Disha Pharmaceutical Business Overview Table 91. Disha Pharmaceutical Bupropion Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Disha Pharmaceutical Bupropion Tablets Product Portfolio Table 93. Disha Pharmaceutical Recent Development Table 94. Zydus Company Information Table 95. Zydus Business Overview Table 96. Zydus Bupropion Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Zydus Bupropion Tablets Product Portfolio Table 98. Zydus Recent Development Table 99. Watson Laboratories Company Information Table 100. Watson Laboratories Business Overview Table 101. Watson Laboratories Bupropion Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Watson Laboratories Bupropion Tablets Product Portfolio Table 103. Watson Laboratories Recent Development Table 104. TWi Pharmaceuticals Company Information Table 105. TWi Pharmaceuticals Business Overview Table 106. TWi Pharmaceuticals Bupropion Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. TWi Pharmaceuticals Bupropion Tablets Product Portfolio Table 108. TWi Pharmaceuticals Recent Development Table 109. Sun Pharma Company Information Table 110. Sun Pharma Business Overview Table 111. Sun Pharma Bupropion Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Sun Pharma Bupropion Tablets Product Portfolio Table 113. Sun Pharma Recent Development Table 114. ScieGen Pharmaceuticals Company Information Table 115. ScieGen Pharmaceuticals Business Overview Table 116. ScieGen Pharmaceuticals Bupropion Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. ScieGen Pharmaceuticals Bupropion Tablets Product Portfolio Table 118. ScieGen Pharmaceuticals Recent Development Table 119. Sandoz Company Information Table 120. Sandoz Business Overview Table 121. Sandoz Bupropion Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Sandoz Bupropion Tablets Product Portfolio Table 123. Sandoz Recent Development Table 124. Lupin Company Information Table 125. Lupin Business Overview Table 126. Lupin Bupropion Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Lupin Bupropion Tablets Product Portfolio Table 128. Lupin Recent Development Table 129. Impax Laboratories Company Information Table 130. Impax Laboratories Business Overview Table 131. Impax Laboratories Bupropion Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Impax Laboratories Bupropion Tablets Product Portfolio Table 133. Impax Laboratories Recent Development Table 134. Epic Pharma Company Information Table 135. Epic Pharma Business Overview Table 136. Epic Pharma Bupropion Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Epic Pharma Bupropion Tablets Product Portfolio Table 138. Epic Pharma Recent Development Table 139. Bausch Company Information Table 140. Bausch Business Overview Table 141. Bausch Bupropion Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Bausch Bupropion Tablets Product Portfolio Table 143. Bausch Recent Development Table 144. Aurobindo Pharma Company Information Table 145. Aurobindo Pharma Business Overview Table 146. Aurobindo Pharma Bupropion Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Aurobindo Pharma Bupropion Tablets Product Portfolio Table 148. Aurobindo Pharma Recent Development Table 149. Apotex Company Information Table 150. Apotex Business Overview Table 151. Apotex Bupropion Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Apotex Bupropion Tablets Product Portfolio Table 153. Apotex Recent Development Table 154. Alembic Company Information Table 155. Alembic Business Overview Table 156. Alembic Bupropion Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Alembic Bupropion Tablets Product Portfolio Table 158. Alembic Recent Development Table 159. Accord Healthcare Company Information Table 160. Accord Healthcare Business Overview Table 161. Accord Healthcare Bupropion Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 162. Accord Healthcare Bupropion Tablets Product Portfolio Table 163. Accord Healthcare Recent Development Table 164. Key Raw Materials Table 165. Raw Materials Key Suppliers Table 166. Bupropion Tablets Distributors List Table 167. Bupropion Tablets Customers List Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. Bupropion Tablets Product Image Figure 2. Global Bupropion Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bupropion Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Bupropion Tablets Sales (2021-2032) & (K Units) Figure 5. Global Bupropion Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Bupropion Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Immediate-release Tablets Image Figure 10. Extended-release Tablets Image Figure 11. Global Bupropion Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Bupropion Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Bupropion Tablets Sales Volume Share by Type (2021-2032) Figure 14. Global Bupropion Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Bupropion Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Bupropion Tablets Sales Value Share by Type (2021-2032) Figure 17. Major Depressive Disorder Image Figure 18. Assisted Smoking Cessation Image Figure 19. Other Image Figure 20. Global Bupropion Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Bupropion Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Bupropion Tablets Sales Volume Share by Application (2021-2032) Figure 23. Global Bupropion Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Bupropion Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Bupropion Tablets Sales Value Share by Application (2021-2032) Figure 26. Global Bupropion Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Bupropion Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Bupropion Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Bupropion Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Bupropion Tablets Sales Value (2021-2032) & (US$ Million) Figure 31. North America Bupropion Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Bupropion Tablets Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Bupropion Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Bupropion Tablets Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Bupropion Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Bupropion Tablets Sales Value (2021-2032) & (US$ Million) Figure 37. South America Bupropion Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Bupropion Tablets Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Bupropion Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Bupropion Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Bupropion Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Bupropion Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Bupropion Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Bupropion Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Bupropion Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Bupropion Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Bupropion Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Bupropion Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Bupropion Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Bupropion Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Bupropion Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Bupropion Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Bupropion Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Bupropion Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Bupropion Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Bupropion Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Bupropion Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Bupropion Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Bupropion Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Bupropion Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Bupropion Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Bupropion Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Bupropion Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Bupropion Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Bupropion Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Bupropion Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Bupropion Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Bupropion Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Bupropion Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Bupropion Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Bupropion Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Bupropion Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Bupropion Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Bupropion Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Bupropion Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Bupropion Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Bupropion Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Bupropion Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Bupropion Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Bupropion Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Bupropion Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Bupropion Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Bupropion Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Bupropion Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Bupropion Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Bupropion Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Bupropion Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Bupropion Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Bupropion Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Bupropion Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Bupropion Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Bupropion Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Bupropion Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Bupropion Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Bupropion Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Bupropion Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Bupropion Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Bupropion Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Bupropion Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Bupropion Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Bupropion Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Bupropion Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Bupropion Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Bupropion Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Bupropion Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Bupropion Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Bupropion Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Bupropion Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Bupropion Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Bupropion Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Bupropion Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Bupropion Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Bupropion Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Bupropion Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Bupropion Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Bupropion Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Bupropion Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Bupropion Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Bupropion Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Bupropion Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Bupropion Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Bupropion Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Bupropion Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Bupropion Tablets Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Bupropion Tablets Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Immediate-release Tablets
  • Extended-release Tablets
Applications
  • Major Depressive Disorder
  • Assisted Smoking Cessation
  • Other
Companies covered
  • GSK
  • Yichang Humanwell Pharmaceutical
  • Sinotherapeutics
  • CSPC Ouyi Pharmaceutical
  • Luye Pharma
  • Disha Pharmaceutical
  • Zydus
  • Watson Laboratories
  • TWi Pharmaceuticals
  • Sun Pharma
  • ScieGen Pharmaceuticals
  • Sandoz
  • Lupin
  • Impax Laboratories
  • Epic Pharma
  • Bausch
  • Aurobindo Pharma
  • Apotex
  • Alembic
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bupropion Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Bupropion Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Bupropion Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Bupropion Tablets Market Dynamics
  1. 2.1 Bupropion Tablets Industry Trends
  2. 2.2 Bupropion Tablets Industry Drivers
  3. 2.3 Bupropion Tablets Industry Opportunities and Challenges
  4. 2.4 Bupropion Tablets Industry Restraints
3 Bupropion Tablets Market by Company
  1. 3.1 Global Bupropion Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Bupropion Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Bupropion Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Bupropion Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Bupropion Tablets Company Ranking (2024-2026)
  6. 3.6 Global Bupropion Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Bupropion Tablets Company Product Type and Application
  8. 3.8 Global Bupropion Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Bupropion Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Bupropion Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Bupropion Tablets Market by Type
  1. 4.1 Bupropion Tablets Type Introduction
  2. 4.1.1 Immediate-release Tablets
  3. 4.1.2 Extended-release Tablets
  4. 4.2 Global Bupropion Tablets Sales Volume by Type
  5. 4.2.1 Global Bupropion Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Bupropion Tablets Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Bupropion Tablets Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Bupropion Tablets Sales Value by Type
  9. 4.3.1 Global Bupropion Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Bupropion Tablets Sales Value by Type (2021-2032)
  11. 4.3.3 Global Bupropion Tablets Sales Value Share by Type (2021-2032)
5 Bupropion Tablets Market by Application
  1. 5.1 Bupropion Tablets Application Introduction
  2. 5.1.1 Major Depressive Disorder
  3. 5.1.2 Assisted Smoking Cessation
  4. 5.1.3 Other
  5. 5.2 Global Bupropion Tablets Sales Volume by Application
  6. 5.2.1 Global Bupropion Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Bupropion Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Bupropion Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Bupropion Tablets Sales Value by Application
  10. 5.3.1 Global Bupropion Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Bupropion Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Bupropion Tablets Sales Value Share by Application (2021-2032)
6 Bupropion Tablets Regional Sales and Value Analysis
  1. 6.1 Global Bupropion Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bupropion Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Bupropion Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Bupropion Tablets Sales by Region (2027-2032)
  5. 6.3 Global Bupropion Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Bupropion Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Bupropion Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Bupropion Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Bupropion Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Bupropion Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Bupropion Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Bupropion Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Bupropion Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Bupropion Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Bupropion Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Bupropion Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Bupropion Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Bupropion Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Bupropion Tablets Sales Value Share by Country, 2025 VS 2032
7 Bupropion Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Bupropion Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Bupropion Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Bupropion Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Bupropion Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Bupropion Tablets Sales by Country (2027-2032)
  6. 7.4 Global Bupropion Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Bupropion Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Bupropion Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Bupropion Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Bupropion Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Bupropion Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Bupropion Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Bupropion Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Bupropion Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Bupropion Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Bupropion Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Bupropion Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Bupropion Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Bupropion Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Bupropion Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Bupropion Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Bupropion Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Bupropion Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Bupropion Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Bupropion Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Bupropion Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Bupropion Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Bupropion Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Bupropion Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Bupropion Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Bupropion Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Bupropion Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Bupropion Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Bupropion Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Bupropion Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Bupropion Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Bupropion Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Bupropion Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Bupropion Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Bupropion Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Bupropion Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Bupropion Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Bupropion Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Bupropion Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Bupropion Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Bupropion Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Bupropion Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Bupropion Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Bupropion Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Bupropion Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Bupropion Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Bupropion Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Bupropion Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Bupropion Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Bupropion Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Bupropion Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Bupropion Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Bupropion Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Bupropion Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Bupropion Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Bupropion Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Bupropion Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Bupropion Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Bupropion Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Bupropion Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Bupropion Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Bupropion Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Bupropion Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Bupropion Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Bupropion Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Bupropion Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Bupropion Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Bupropion Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Bupropion Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Bupropion Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Bupropion Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Bupropion Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Bupropion Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Bupropion Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Bupropion Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Bupropion Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Bupropion Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Bupropion Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Bupropion Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Bupropion Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Bupropion Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Bupropion Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Bupropion Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Bupropion Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Bupropion Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Bupropion Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Bupropion Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GSK
  2. 8.1.1 GSK Company Information
  3. 8.1.2 GSK Business Overview
  4. 8.1.3 GSK Bupropion Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 GSK Bupropion Tablets Product Portfolio
  6. 8.1.5 GSK Recent Developments
  7. 8.2 Yichang Humanwell Pharmaceutical
  8. 8.2.1 Yichang Humanwell Pharmaceutical Company Information
  9. 8.2.2 Yichang Humanwell Pharmaceutical Business Overview
  10. 8.2.3 Yichang Humanwell Pharmaceutical Bupropion Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Yichang Humanwell Pharmaceutical Bupropion Tablets Product Portfolio
  12. 8.2.5 Yichang Humanwell Pharmaceutical Recent Developments
  13. 8.3 Sinotherapeutics
  14. 8.3.1 Sinotherapeutics Company Information
  15. 8.3.2 Sinotherapeutics Business Overview
  16. 8.3.3 Sinotherapeutics Bupropion Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sinotherapeutics Bupropion Tablets Product Portfolio
  18. 8.3.5 Sinotherapeutics Recent Developments
  19. 8.4 CSPC Ouyi Pharmaceutical
  20. 8.4.1 CSPC Ouyi Pharmaceutical Company Information
  21. 8.4.2 CSPC Ouyi Pharmaceutical Business Overview
  22. 8.4.3 CSPC Ouyi Pharmaceutical Bupropion Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 CSPC Ouyi Pharmaceutical Bupropion Tablets Product Portfolio
  24. 8.4.5 CSPC Ouyi Pharmaceutical Recent Developments
  25. 8.5 Luye Pharma
  26. 8.5.1 Luye Pharma Company Information
  27. 8.5.2 Luye Pharma Business Overview
  28. 8.5.3 Luye Pharma Bupropion Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Luye Pharma Bupropion Tablets Product Portfolio
  30. 8.5.5 Luye Pharma Recent Developments
  31. 8.6 Disha Pharmaceutical
  32. 8.6.1 Disha Pharmaceutical Company Information
  33. 8.6.2 Disha Pharmaceutical Business Overview
  34. 8.6.3 Disha Pharmaceutical Bupropion Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Disha Pharmaceutical Bupropion Tablets Product Portfolio
  36. 8.6.5 Disha Pharmaceutical Recent Developments
  37. 8.7 Zydus
  38. 8.7.1 Zydus Company Information
  39. 8.7.2 Zydus Business Overview
  40. 8.7.3 Zydus Bupropion Tablets Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Zydus Bupropion Tablets Product Portfolio
  42. 8.7.5 Zydus Recent Developments
  43. 8.8 Watson Laboratories
  44. 8.8.1 Watson Laboratories Company Information
  45. 8.8.2 Watson Laboratories Business Overview
  46. 8.8.3 Watson Laboratories Bupropion Tablets Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Watson Laboratories Bupropion Tablets Product Portfolio
  48. 8.8.5 Watson Laboratories Recent Developments
  49. 8.9 TWi Pharmaceuticals
  50. 8.9.1 TWi Pharmaceuticals Company Information
  51. 8.9.2 TWi Pharmaceuticals Business Overview
  52. 8.9.3 TWi Pharmaceuticals Bupropion Tablets Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 TWi Pharmaceuticals Bupropion Tablets Product Portfolio
  54. 8.9.5 TWi Pharmaceuticals Recent Developments
  55. 8.10 Sun Pharma
  56. 8.10.1 Sun Pharma Company Information
  57. 8.10.2 Sun Pharma Business Overview
  58. 8.10.3 Sun Pharma Bupropion Tablets Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Sun Pharma Bupropion Tablets Product Portfolio
  60. 8.10.5 Sun Pharma Recent Developments
  61. 8.11 ScieGen Pharmaceuticals
  62. 8.11.1 ScieGen Pharmaceuticals Company Information
  63. 8.11.2 ScieGen Pharmaceuticals Business Overview
  64. 8.11.3 ScieGen Pharmaceuticals Bupropion Tablets Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 ScieGen Pharmaceuticals Bupropion Tablets Product Portfolio
  66. 8.11.5 ScieGen Pharmaceuticals Recent Developments
  67. 8.12 Sandoz
  68. 8.12.1 Sandoz Company Information
  69. 8.12.2 Sandoz Business Overview
  70. 8.12.3 Sandoz Bupropion Tablets Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Sandoz Bupropion Tablets Product Portfolio
  72. 8.12.5 Sandoz Recent Developments
  73. 8.13 Lupin
  74. 8.13.1 Lupin Company Information
  75. 8.13.2 Lupin Business Overview
  76. 8.13.3 Lupin Bupropion Tablets Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Lupin Bupropion Tablets Product Portfolio
  78. 8.13.5 Lupin Recent Developments
  79. 8.14 Impax Laboratories
  80. 8.14.1 Impax Laboratories Company Information
  81. 8.14.2 Impax Laboratories Business Overview
  82. 8.14.3 Impax Laboratories Bupropion Tablets Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Impax Laboratories Bupropion Tablets Product Portfolio
  84. 8.14.5 Impax Laboratories Recent Developments
  85. 8.15 Epic Pharma
  86. 8.15.1 Epic Pharma Company Information
  87. 8.15.2 Epic Pharma Business Overview
  88. 8.15.3 Epic Pharma Bupropion Tablets Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Epic Pharma Bupropion Tablets Product Portfolio
  90. 8.15.5 Epic Pharma Recent Developments
  91. 8.16 Bausch
  92. 8.16.1 Bausch Company Information
  93. 8.16.2 Bausch Business Overview
  94. 8.16.3 Bausch Bupropion Tablets Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Bausch Bupropion Tablets Product Portfolio
  96. 8.16.5 Bausch Recent Developments
  97. 8.17 Aurobindo Pharma
  98. 8.17.1 Aurobindo Pharma Company Information
  99. 8.17.2 Aurobindo Pharma Business Overview
  100. 8.17.3 Aurobindo Pharma Bupropion Tablets Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Aurobindo Pharma Bupropion Tablets Product Portfolio
  102. 8.17.5 Aurobindo Pharma Recent Developments
  103. 8.18 Apotex
  104. 8.18.1 Apotex Company Information
  105. 8.18.2 Apotex Business Overview
  106. 8.18.3 Apotex Bupropion Tablets Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Apotex Bupropion Tablets Product Portfolio
  108. 8.18.5 Apotex Recent Developments
  109. 8.19 Alembic
  110. 8.19.1 Alembic Company Information
  111. 8.19.2 Alembic Business Overview
  112. 8.19.3 Alembic Bupropion Tablets Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Alembic Bupropion Tablets Product Portfolio
  114. 8.19.5 Alembic Recent Developments
  115. 8.20 Accord Healthcare
  116. 8.20.1 Accord Healthcare Company Information
  117. 8.20.2 Accord Healthcare Business Overview
  118. 8.20.3 Accord Healthcare Bupropion Tablets Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Accord Healthcare Bupropion Tablets Product Portfolio
  120. 8.20.5 Accord Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Bupropion Tablets Value Chain Analysis
  2. 9.1.1 Bupropion Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Bupropion Tablets Sales Mode & Process
  6. 9.2 Bupropion Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Bupropion Tablets Distributors
  9. 9.2.3 Bupropion Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst